Lexicon Pharmaceuticals
LXRX
#6429
Rank
โ‚ฌ0.84 B
Marketcap
1,91ย โ‚ฌ
Share price
6.86%
Change (1 day)
93.83%
Change (1 year)

EPS for Lexicon Pharmaceuticals (LXRX)

EPS in 2026 (TTM): -0,05965ย โ‚ฌ

According to Lexicon Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -0,06118ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,12ย โ‚ฌ an increase over its 2024 EPS that were of -0,56ย โ‚ฌ.

EPS history for Lexicon Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,05965ย โ‚ฌ-51.25%
2025-0,12ย โ‚ฌ-78.13%
2024-0,56ย โ‚ฌ-20%
2023-0,70ย โ‚ฌ31.15%
2022-0,53ย โ‚ฌ-0%
2021-0,53ย โ‚ฌ10.91%
2020-0,48ย โ‚ฌ-145.08%
20191,07ย โ‚ฌ-206.09%
2018-1,01ย โ‚ฌ-5.74%
2017-1,07ย โ‚ฌ-10.95%
2016-1,20ย โ‚ฌ2640%
2015-0,04370ย โ‚ฌ-96.34%
2014-1,19ย โ‚ฌ-2.53%
2013-1,22ย โ‚ฌ-9.09%
2012-1,35ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
15,92ย โ‚ฌ-26,128.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
4,83ย โ‚ฌ-8,000.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
37,17ย โ‚ฌ-60,857.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-5,34ย โ‚ฌ 8,628.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
6,85ย โ‚ฌ-11,300.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-0,01748ย โ‚ฌ-71.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-0,66ย โ‚ฌ 971.43%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
1,22ย โ‚ฌ-2,100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-1.431ย โ‚ฌ 2,338,114.29%๐Ÿ‡บ๐Ÿ‡ธ USA